These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 26324814)

  • 1. Therapeutic strategies in pneumonia: going beyond antibiotics.
    Müller-Redetzky H; Lienau J; Suttorp N; Witzenrath M
    Eur Respir Rev; 2015 Sep; 24(137):516-24. PubMed ID: 26324814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New Pathogenetic Concepts and Pharmacological Studies on Adjuvant Therapy in Severe Pneumonia].
    Lienau J; Müller-Redetzky H; Suttorp N; Witzenrath M
    Pneumologie; 2016 Jun; 70(6):372-8. PubMed ID: 26637049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate Immune Signaling Activated by MDR Bacteria in the Airway.
    Parker D; Ahn D; Cohen T; Prince A
    Physiol Rev; 2016 Jan; 96(1):19-53. PubMed ID: 26582515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary Innate Immune Response Determines the Outcome of Inflammation During Pneumonia and Sepsis-Associated Acute Lung Injury.
    Kumar V
    Front Immunol; 2020; 11():1722. PubMed ID: 32849610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumonia models and innate immunity to respiratory bacterial pathogens.
    Knapp S; Schultz MJ; van der Poll T
    Shock; 2005 Dec; 24 Suppl 1():12-8. PubMed ID: 16374367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1 receptor-associated kinase M-deficient mice demonstrate an improved host defense during Gram-negative pneumonia.
    Hoogerwerf JJ; van der Windt GJ; Blok DC; Hoogendijk AJ; De Vos AF; van 't Veer C; Florquin S; Kobayashi KS; Flavell RA; van der Poll T
    Mol Med; 2012 Sep; 18(1):1067-75. PubMed ID: 22729155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New aspects of the pathophysiology of pneumonia].
    Hippenstiel S; Witzenrath M; Opitz B; Schütte H; Rosseau S; Suttorp N
    Internist (Berl); 2007 May; 48(5):459-60, 462-4, 466-7. PubMed ID: 17429589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic di-GMP stimulates protective innate immunity in bacterial pneumonia.
    Karaolis DK; Newstead MW; Zeng X; Hyodo M; Hayakawa Y; Bhan U; Liang H; Standiford TJ
    Infect Immun; 2007 Oct; 75(10):4942-50. PubMed ID: 17646358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol abuse, immunosuppression, and pulmonary infection.
    Zhang P; Bagby GJ; Happel KI; Raasch CE; Nelson S
    Curr Drug Abuse Rev; 2008 Jan; 1(1):56-67. PubMed ID: 19630706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of nosocomial pneumonia in ALI/ARDS patients.
    Fagon JY; Chastre J
    Eur Respir J Suppl; 2003 Aug; 42():77s-83s. PubMed ID: 12946005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postviral Complications: Bacterial Pneumonia.
    Prasso JE; Deng JC
    Clin Chest Med; 2017 Mar; 38(1):127-138. PubMed ID: 28159155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broad-spectrum suppression of bacterial pneumonia by aminoglycoside-propagated Acinetobacter baumannii.
    Hood-Pishchany MI; Pham L; Wijers CD; Burns WJ; Boyd KL; Palmer LD; Skaar EP; Noto MJ
    PLoS Pathog; 2020 Mar; 16(3):e1008374. PubMed ID: 32168364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial community-acquired pneumonia: risk factors for mortality and supportive therapies.
    Lode H
    Intensive Care Med; 2009 Mar; 35(3):391-3. PubMed ID: 19066849
    [No Abstract]   [Full Text] [Related]  

  • 14. Lung inflammatory pattern and antibiotic treatment in pneumonia.
    Lorenzo MJ; Moret I; Sarria B; Cases E; Cortijo J; Méndez R; Molina J; Gimeno A; Menéndez R
    Respir Res; 2015 Feb; 16(1):15. PubMed ID: 25849726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult respiratory distress syndrome due to Chlamydia pneumoniae in a young adult.
    Panagou P; Tsipra S; Bouros D
    Respir Med; 1996 May; 90(5):311-3. PubMed ID: 9499816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of leukotrienes in antimicrobial host defense of the lung.
    Peters-Golden M; Coffey M
    Clin Rev Allergy Immunol; 1999; 17(1-2):261-9. PubMed ID: 10436871
    [No Abstract]   [Full Text] [Related]  

  • 17. 2-Chloroadenosine (2-CADO) treatment modulates the pro-inflammatory immune response to prevent acute lung inflammation in BALB/c mice suffering from Klebsiella pneumoniae B5055-induced pneumonia.
    Kumar V; Harjai K; Chhibber S
    Int J Antimicrob Agents; 2010 Jun; 35(6):599-602. PubMed ID: 20189776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prekallikrein inhibits innate immune signaling in the lung and impairs host defense during pneumosepsis in mice.
    Ding C; Scicluna BP; Stroo I; Yang J; Roelofs JJ; de Boer OJ; de Vos AF; Nürnberg P; Revenko AS; Crosby J; Van't Veer C; van der Poll T
    J Pathol; 2020 Jan; 250(1):95-106. PubMed ID: 31595971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of Progranulin to Protective Lung Immunity During Bacterial Pneumonia.
    Zou S; Luo Q; Song Z; Zhang L; Xia Y; Xu H; Xiang Y; Yin Y; Cao J
    J Infect Dis; 2017 Jun; 215(11):1764-1773. PubMed ID: 28595330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombocytopenia impairs host defense in gram-negative pneumonia-derived sepsis in mice.
    de Stoppelaar SF; van 't Veer C; Claushuis TA; Albersen BJ; Roelofs JJ; van der Poll T
    Blood; 2014 Dec; 124(25):3781-90. PubMed ID: 25301709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.